Biotech · Public company · Waltham, MA, US

Crescent Biopharma, Inc.

Ticker CBIO · SEC CIK 0001253689

Track this companyFree. Adds Crescent Biopharma, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials22 recruiting or active

Pipeline programs7From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availableNo recent cash burn filed

Pipeline7

CarboplatinPhase 2 · Locally Advanced / Metastatic Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
CR-001Phase 2 · Locally Advanced / Metastatic Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
CR-002Phase 2 · Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M)ClinicalTrials.gov · fetched Nov 12, 2026
OxaliplatinPhase 2 · Locally Advanced / Metastatic Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
PaclitaxelPhase 2 · Locally Advanced / Metastatic Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
PemetrexedPhase 2 · Locally Advanced / Metastatic Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
trifluridine and tipiracilPhase 2 · Locally Advanced / Metastatic Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026

CR-002 in Adult Participants With Locally Advanced or Metastatic Solid TumorsPHASE1_PHASE2 · RECRUITING · started Oct 21, 2026ClinicalTrials.gov NCT07909031 · fetched Nov 12, 2026
CR-001 in Adult Participants With Locally Advanced or Metastatic Solid TumorsPHASE1_PHASE2 · RECRUITING · started Feb 17, 2026ClinicalTrials.gov NCT07335497 · fetched Nov 12, 2026